SEOULEAGUER Past Earnings Performance
Past criteria checks 0/6
SEOULEAGUER has been growing earnings at an average annual rate of 15.9%, while the Healthcare industry saw earnings growing at 12.9% annually. Revenues have been declining at an average rate of 36.4% per year.
Key information
15.9%
Earnings growth rate
25.3%
EPS growth rate
| Healthcare Industry Growth | 34.2% |
| Revenue growth rate | -36.4% |
| Return on equity | -41.7% |
| Net Margin | -64.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How SEOULEAGUER makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 19,066 | -12,327 | 6,589 | 0 |
| 31 Mar 24 | 20,443 | -17,378 | 7,922 | 0 |
| 31 Dec 23 | 22,559 | -3,296 | 7,865 | 0 |
| 30 Sep 23 | 20,298 | 12,810 | 6,973 | 0 |
| 30 Jun 23 | 17,344 | 11,093 | 7,439 | 0 |
| 31 Mar 23 | 15,005 | 12,820 | 6,897 | 0 |
| 31 Dec 22 | 10,107 | -6,385 | 7,067 | 0 |
| 30 Sep 22 | -8,101 | -7,656 | -6,542 | 0 |
| 30 Jun 22 | -8,151 | -9,612 | -7,216 | 0 |
| 31 Mar 22 | 8,774 | -930 | -9,247 | 0 |
| 31 Dec 21 | 14,874 | -1,206 | -3,670 | 0 |
| 30 Sep 21 | 3,809 | 6,440 | -12,254 | 0 |
| 30 Jun 21 | 10,061 | 1,870 | -459 | 0 |
| 31 Mar 21 | 10,789 | -8,082 | 10,760 | 0 |
| 31 Dec 20 | 13,601 | -6,654 | 12,287 | 0 |
| 30 Sep 20 | 66,974 | -19,023 | 44,132 | 0 |
| 30 Jun 20 | 86,594 | -11,463 | 43,696 | 0 |
| 31 Mar 20 | 75,656 | -8,987 | 33,243 | 0 |
| 31 Dec 19 | 73,137 | -6,401 | 25,047 | 0 |
| 30 Sep 19 | 53,387 | -5,821 | 15,172 | 0 |
| 30 Jun 19 | 28,599 | -3,785 | 2,535 | 0 |
| 31 Mar 19 | 22,420 | -3,956 | 3,174 | 0 |
| 31 Dec 18 | 17,511 | -3,831 | 3,260 | 0 |
| 30 Sep 18 | 13,505 | 370 | 3,259 | 0 |
| 30 Jun 18 | 12,757 | -761 | 3,619 | 0 |
| 31 Mar 18 | 12,746 | 1,203 | 3,000 | 0 |
| 31 Dec 17 | 14,284 | -679 | 2,879 | 0 |
| 30 Sep 17 | 21,799 | -8 | 651 | 0 |
| 30 Jun 17 | 24,573 | -1,727 | 1,369 | 0 |
| 31 Mar 17 | 22,766 | -2,402 | 1,285 | 0 |
| 31 Dec 16 | 18,484 | -143 | 1,019 | 0 |
| 30 Sep 16 | 6,966 | -903 | 1,841 | 255 |
| 30 Jun 16 | 1,844 | -259 | 2,570 | 255 |
| 31 Mar 16 | 547 | -1,461 | 1,468 | 405 |
| 31 Dec 15 | 715 | -2,158 | 1,492 | 684 |
| 30 Sep 15 | 2,415 | -2,095 | 1,726 | 429 |
| 30 Jun 15 | 2,127 | -2,269 | 314 | 429 |
| 31 Mar 15 | 2,440 | -3,677 | 1,353 | 279 |
| 31 Dec 14 | 7,759 | -7,371 | 7,221 | 0 |
| 30 Sep 14 | 15,310 | -18,024 | 8,484 | 0 |
| 30 Jun 14 | 23,135 | -18,241 | 8,669 | 0 |
| 31 Mar 14 | 32,319 | -16,012 | 8,853 | 0 |
| 31 Dec 13 | 36,991 | -11,639 | 3,105 | 0 |
| 30 Sep 13 | 43,232 | -888 | 2,329 | 0 |
Quality Earnings: A043710 is currently unprofitable.
Growing Profit Margin: A043710 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A043710 is unprofitable, but has reduced losses over the past 5 years at a rate of 15.9% per year.
Accelerating Growth: Unable to compare A043710's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A043710 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.2%).
Return on Equity
High ROE: A043710 has a negative Return on Equity (-41.66%), as it is currently unprofitable.